FTDI
RGNX icon

First Trust Direct Indexing’s Regenxbio RGNX Stock Holding History

First Trust Direct Indexing’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,327
Closed -$60K – 863
2020
Q4 		$60K Buy
+1,327
New +$46.4K 0.02% 703

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Trust Direct Indexing's RGNX Position: Q1 2021 in Review

First Trust Direct Indexing sold out of Regenxbio (RGNX) in Q1 2021, closing a stake of 1,327 shares — an estimated $60K sold.

First Trust Direct Indexing first reported a position in RGNX in Q4 2020 and held it in 1 quarter. The position peaked at $60K in Q4 2020. 184 funds tracked by Wall St. Rank hold RGNX as of Q1 2021.

  • First Trust Direct Indexing reported no remaining Regenxbio position as of Q1 2021 after selling out during the quarter.
  • First Trust Direct Indexing sold 1,327 Regenxbio shares in Q1 2021, an estimated $60K.
  • First Trust Direct Indexing first reported a position in Regenxbio in Q4 2020 and held it in 1 quarter.
  • First Trust Direct Indexing's Regenxbio position peaked at $60K in Q4 2020.
  • 184 funds tracked by Wall St. Rank held Regenxbio as of Q1 2021.

Based on First Trust Direct Indexing's 13F filing for Q1 2021, filed 14 Apr 2021.